Non Product Specific: payments to doctors
Payments that named Non Product Specific as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $111K
- Providers
- 39
- Transactions
- 45
- Average per transaction
- $2,476
The per-transaction average — $2,476 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 39 providers the average total is $2,857, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Roche Diagnostics Corporation | $95,637 | 85.8% |
| Boehringer Ingelheim International GmbH | $6,746 | 6.1% |
| Boehringer Ingelheim (china) Investment Co., Ltd. | $6,550 | 5.9% |
| Boehringer Ingelheim Mexico SA De CV | $2,501 | 2.2% |